23 results on '"Desse, Javier"'
Search Results
2. Enfermedad de Chagas-Mazza congenita en Salta
- Author
-
Contreras Silvia, Fernandez María Rosa, Agüero Fernando, Desse Desse Javier, Orduna Tomás, and Martino Olindo
- Subjects
Enfermedad de Chagas-Mazza ,Transmisión congénita ,Incidencia ,Diagnóstico ,Tratamiento ,Arctic medicine. Tropical medicine ,RC955-962 - Abstract
Se estudió la infección por T. cruzi en mujeres embarazadas en la localidad de General Güemes, provincia de Salta. La misma fue del 12,3 %. El 8,8% de los recién nacidos estudiados tuvieron diagnóstico de Enfermedad de Chagas utilizando la técnica directa (microhematocrito). Todos fueron tratados con benznidazol a razón de 5mg/kg/día durante 30 dias. Todos presentaron anemia, que fue interpretada como reacción adversa medicamentosa. Se estima que la técnica directa representa la mejor opción para llevar a cabo el diagnóstico de esta enfermedad en el recién nacido. Se ha propuesto un flujograma para el seguimiento de la infección por T. cruzi en el recién nacido.
- Published
- 1999
3. Estudio sobre la exposicion ocupacional a sangre y fluidos corporales en el personal de enfermeria de un hospital de referencia de Buenos Aires, Argentina
- Author
-
Warley, Eduardo, Pereyra, Nancy, Desse, Javier, Cetani, Silvia, de Luca, Adriana, Tamayo Antabak, Natalia, and Szyld, Edgardo
- Published
- 2009
4. 12 pasos para reducir la incidencia de carbapenemasas
- Author
-
Clara, Liliana, primary, Desse, Javier, additional, Nuccetelli, Yanina, additional, Colque, Ángel, additional, Di Libero, Eugenia, additional, and Staneloni, María Inés, additional
- Published
- 2021
- Full Text
- View/download PDF
5. Consenso Argentino intersociedades de Infección Urinaria 2018-2019 - Parte II
- Author
-
Nemirovsky, Corina, López Furst, María José, Pryluka, Daniel, De Vedia, Lautaro, Scapellato, Pablo, Colque, Angel, Barcelona, Laura, Desse, Javier, Caradonti, Matías, Varcasia, Daniel, Ipohorski, Gabriel, Votta, Roberto, Zylberman, Marcelo, Roman, Adriana, Valdez, Pascual, Amalfa, Flavia, Lucero, Celeste, Fernández Lausi, Adriana, Fernández Garces, Alejandro, Rodríguez, Claudia, Chattas, Ana, Farina, Javier, Clara, Liliana, and Nuccetelli, Yanina
- Subjects
Adult ,Catéteres urinarios ,Agentes antimicrobianos urinarios ,Litiasis renal ,Adulto ,Lipotripsia ,Urinary catheters ,Lithotripsy ,Kidney calculi ,Urinary anti-infective agents ,Prostatitis - Abstract
La segunda parte del Consenso Argentino Intersociedades de Infección Urinaria incluye el análisis de situaciones especiales. En pacientes con sonda vesical se debe solicitar urocultivo solo cuando hay signo-sintomatología de infección del tracto urinario, antes de instrumentaciones de la vía urinaria o como control en pacientes post-trasplante renal. El tratamiento empírico recomendado en pacientes sin factores de riesgo es cefalosporinas de tercera generación o aminoglucósidos. Las infecciones del tracto urinario asociadas a cálculos son siempre consideradas complicadas. En caso de obstrucción con urosepsis, deberá realizarse drenaje de urgencia por vía percutánea o ureteral. En pacientes con stents o prótesis ureterales, como catéteres doble J, el tratamiento empírico deberá basarse en la epidemiología, los antibióticos previos y el estado clínico. Antes del procedimiento de litotricia extracorpórea se recomienda pesquisar la bacteriuria y, si es positiva, administrar profilaxis antibiótica según el antibiograma. Cefalosporinas de primera generación o aminoglúcosidos son opciones válidas. Se recomienda aplicar profilaxis antibiótica con cefalosporinas de primera generación o aminoglúcosidos antes de la nefrolitotomía percutánea. La biopsia prostática trans-rectal puede asociarse a complicaciones infecciosas, como infecciones del tracto urinario o prostatitis aguda, principalmente por Escherichia coli u otras enterobacterias. En pacientes sin factores de riesgo para gérmenes multirresistentes y urocultivo negativo se recomienda realizar profilaxis con amikacina o ceftriaxona endovenosas. En pacientes con urocultivo positivo, se realizará profilaxis según antibiograma, 24 horas previas a 24 horas post-procedimiento. Para el tratamiento dirigido de la prostatitis post-biopsia trans-rectal, los carbapenémicos durante 3-4 semanas son el tratamiento de elección. The second part of the Inter-Society Argentine Consensus on Urinary Tract Infection (UTI) includes the analysis of special situations. In patients with urinary catheter, urine culture should be requested only in the presence of UTI symptomatology, before instrumentation of the urinary tract, or as a post-transplant control. The antibiotics recommended for empirical treatment in patients without risk factors are third-generation cephalosporins or aminoglycosides. UTIs associated with stones are always considered complicated. In case of obstruction with urosepsis, an emergency drainage should be performed via a percutaneous nefrostomy or ureteral stenting. In patients with stents or ureteral prostheses, such as double J catheters, empirical treatment should be based on epidemiology, prior antibiotics, and clinical status. Before the extracorporeal lithotripsy procedure, bacteriuria should be investigated and antibiotic prophylaxis should be administered in case of positive result, according to the antibiogram. First generation cephalosporins or aminoglycosides are valid alternatives. The use of antibiotic prophylaxis with first-generation cephalosporins or aminoglycosides before percutaneous nephrolithotomy is recommended. Transrectal prostatic biopsy can be associated with infectious complications, such as UTI or acute prostatitis, mainly due to Escherichia coli or other enterobacteria. In patients without risk factors for multiresistant bacteria and negative urine culture, prophylaxis with intravenous amikacin or ceftriaxone is recommended. In patients with positive urine culture, prophylaxis will be performed according to the antibiogram, from 24 hours before to 24 hours post-procedure. For the targeted treatment of post-transrectal biopsy prostatitis, carbapenems for 3-4 weeks are the treatment of choice.
- Published
- 2020
6. CONTROVERSIAS DURANTE LA PANDEMIA DE COVID-19.
- Author
-
CORNISTEIN, WANDA, DESSE, JAVIER, NUCCETELLI, YANINA, SANTONATO, DANIELA, RODRÍGUEZ, VIVIANA M., DE CRISTÓFANO, ANALÍA, STANELONI, MARÍA INÉS, HERRERA, MARÍA PAULA, and COLQUE, ÁNGEL
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
7. Neumonía asociada a cuidados de la salud: revisión de la evidencia publicada
- Author
-
De Vedia, Lautaro, primary, Di Líbero, Eugenia, additional, Scapellato, Pablo, additional, and Desse, Javier, additional
- Published
- 2018
- Full Text
- View/download PDF
8. Impact of the International Nosocomial Infection Control Consortium (INICC)’s Multidimensional Approach on Rates of Central Line-Associated Bloodstream Infection in 14 Intensive Care Units in 11 Hospitals of 5 Cities in Argentina
- Author
-
Rosenthal, Victor Daniel, primary, Desse, Javier, additional, Maurizi, Diego Marcelo, additional, Chaparro, Gustavo Jorge, additional, Orellano, Pablo Wenceslao, additional, Chediack, Viviana, additional, Cabrera, Rafael, additional, Golschmid, Daniel, additional, Silva, Cristina Graciela, additional, Vimercati, Julio Cesar, additional, Stagnaro, Juan Pablo, additional, Perez, Ivanna, additional, Spadaro, María Laura, additional, Montanini, Adriana Miriam, additional, Pedersen, Dina, additional, Paniccia, Teresa Laura, additional, Aguilera, Ana María Ríos, additional, Cermesoni, Raul, additional, Mele, Juan Ignacio, additional, Alda, Ernesto, additional, Paldoro, Analía Edith, additional, Ortta, Agustín Román, additional, Cooke, Bettina, additional, García, María Cecilia, additional, Obed, Mora Nair, additional, Domínguez, Cecilia Verónica, additional, Saúl, Pablo Alejandro, additional, Rodríguez del Valle, María Cecilia, additional, Bianchi, Alberto Claudio, additional, Alvarez, Gustavo, additional, Pérez, Ricardo, additional, and Oyola, Carolina, additional
- Published
- 2018
- Full Text
- View/download PDF
9. RECOMENDACIONES INTERSOCIEDADES PARA DIAGNÓSTICO, TRATAMIENTO Y PREVENCIÓN DE LAS INFECCIONES POR CLOSTRIDIOIDES DIFFICILE.
- Author
-
BARCÁN, LAURA, DUCATENZEILER, LAURA, DEL CARMEN BANGHER, MARÍA, BARCELONA, LAURA, CORNISTEIN, WANDA, DACIUK, LUCÍA, DE PAULA, JUAN, DESSE, JAVIER, DICTAR, MIGUEL, FERNÁNDEZ-CANIGIA, LILIANA, NACINOVICH, FRANCISCO, SCAPELLATO, PABLO, and VICTOR MARTÍNEZ, JORGE
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2020
10. NEUMONÍA ADQUIRIDA DE LA COMUNIDAD EN ADULTOS. RECOMENDACIONES SOBRE SU ATENCIÓN.
- Author
-
LOPARDO, GUSTAVO, BASOMBRÍO, ADRIANA, CLARA, LILIANA, DESSE, JAVIER, DE VEDIA, LAUTARO, DI LIBERO, EUGENIA, GAÑETE, MARCELO, LÓPEZ FURST, MARÍA JOSÉ, MYKIETIUK, ANALÍA, NEMIROVSKY, CORINA, OSUNA, CAROLINA, PENSOTTI, CLAUDIA, and SCAPELLATO, PABLO
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2015
11. Acute disseminated histoplasmosis and endocarditis
- Author
-
SCAPELLATO, Pablo G., primary, DESSE, Javier, additional, and NEGRONI, Ricardo, additional
- Published
- 1998
- Full Text
- View/download PDF
12. FACTORES ASOCIADOS AL ESTADIO CLÍNICO AVANZADO EN EL INICIO DE LA TERAPIA ANTIRRETROVIRAL.
- Author
-
WARLEY, EDUARDO, GALIMBERTI, GUILLERMO FERNÁNDEZ, VIENI, MARÍA INÉS, TAVELLA, SILVINA, SALAS, MÓNICA, DESSE, JAVIER, D'AGOSTINO, GRACIELA, and SZYLD, EDGARDO
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2012
13. DESARROLLO DE NEOPLASIAS E INFECCIONES DEFINITORIAS DE SIDA DESPUES DE INICIAR LA TERAPIA ANTIRRETROVIRAL DE ALTA EFICACIA.
- Author
-
Warley, Eduardo, Antabak, Natalia Tamayo, Desse, Javier, de Luca, Adriana, Warley, Fernando, Galimberti, Guillermo Fernandez, D'Agostino, Graciela, Quintas, Luis, and Szyld, Edgardo
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2010
14. CARACTERISTICAS DE LA INFECCION POR HIV/SIDA SEGUN SEXO EN UNA REGION DEL GRAN BUENOS AIRES. PERIODOS 1998-2002/2003-2005.
- Author
-
Warley, Eduardo, Antabak, Natalia Tamayo, Desse, Javier, De Luca, Adriana, Warley, Fernando, Salas, Monica, Vieni, Ines, Szyld, Edgardo, and Indyk, Debbie
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2009
15. [Controversies during the COVID-19 pandemic].
- Author
-
Cornistein W, Desse J, Nuccetelli Y, Santonato D, Rodríguez VM, De Cristófano A, Staneloni MI, Herrera MP, and Colque A
- Subjects
- Humans, Masks, SARS-CoV-2, COVID-19, Pandemics prevention & control
- Abstract
The COVID-19 pandemic has had an impact on public health and the global economy. The objective of this document was to update, according to the available evidence, the management of some basic elements in the Infection Control Programs (PCI) and the daily care of patients. As a result: 1. The routine use of the N95 masks is not recommended for the care of suspected or confirmed COVID-19 patients. Available data indicates that SARS-CoV-2 has spread primarily like most other common respiratory viruses, through droplet and contact transmission. In certain situations, personto-person transmission is described through the airway, observed in poorly ventilated environments, and while the individual carried out actions of greater potential transmission 2. The limited reuse and decontamination methods of N95 masks are accepted under safe and effective prot ocols in the context of limited resources. 3. The isolation of patients with COVID-19 can be lifted under a strategy based on the clinic, individual risk factors and time of evolution of the disease. 4. PCR control is not required in confirmed cases to determine epidemiological discharge. 5. Current evidence shows that there is a possibility of reinfection although its diagnosis is difficult. 6. The measurement of antibodies has a specific role in prevalence studies, diagnosis of multisystemic inflammatory syndrome and a picture compatible with negative PCR after the 7th. day.
- Published
- 2021
16. [Consenso Argentino Intersociedades de Infección Urinaria 2018-2019 - Parte I].
- Author
-
Nemirovsky C, López Furst MJ, Pryluka D, De Vedia L, Scapellato P, Colque A, Barcelona L, Desse J, Caradonti M, Varcasia D, Ipohorski G, Votta R, Zylberman M, Romani A, Valdez P, Penini M, De Paulis A, Lucero C, Sandor A, Contreras R, Nannini E, Gañete M, Ralli H, Lopardo G, Mykietiuk A, and Aronson S
- Subjects
- Argentina, Cystitis diagnosis, Cystitis drug therapy, Female, Humans, Male, Pregnancy, Prospective Studies, Prostatitis diagnosis, Prostatitis drug therapy, Pyelonephritis diagnosis, Pyelonephritis drug therapy, Urinary Tract Infections diagnosis, Anti-Infective Agents, Urinary therapeutic use, Consensus, Urinary Tract Infections drug therapy
- Abstract
The Argentine Society of Infectious Diseases and other scientific societies have updated these recommendations based on data on urinary tract infections in adults obtained from a prospective multicenter study conducted in Argentina during 2016-2017. Asymptomatic bacteriuria should be treated only in pregnant women, who should also be systematically investigated; the antibiotics of choice are nitrofurantoin, amoxicillin, clavulanic/amoxicillin, cephalexin and trimethoprim-sulfamethoxazole. In procedures involving injury to the urinary tract with bleeding, it is recommended to request urine culture and, in the presence of bacteriuria, antimicrobial treatment according to sensitivity should be prescribed from immediately before up to 24 hours after the intervention. In women, cystitis can be treated with nitrofurantoin, cephalexin or fosfomycin, while trimethoprim-sulfamethoxazole and fluoroquinolones are not recommended; pyelonephritis can be treated with ciprofloxacin, cefixime or cephalexin in ambulatory women or ceftriaxone, cefazolin or amikacin in those who are hospitalized. In men, urinary tract infections are always considered complicated; nitrofurantoin or cephalexin are recommended for 7 days, alternatively fosfomycin should be given in a single dose. In men, ciprofloxacin, ceftriaxone or cefixime are suggested for pyelonephritis on ambulatory treatment whereas ceftriaxone or amikacin are recommended for hospitalized patients. Acute bacterial prostatitis can be treated with ceftriaxone or gentamicin. Fluoroquinolones were the choice treatment for chronic bacterial prostatitis until recently; they are no longer recommended due to the increasing resistance and recent concerns regarding the safety of these drugs; alternative antibiotics such as fosfomycin are to be considered.
- Published
- 2020
17. [Argentine Intersociety Consensus on Urinary Infection 2018-2019 - Part II].
- Author
-
Nemirovsky C, López Furst MJ, Pryluka D, De Vedia L, Scapellato P, Colque A, Barcelona L, Desse J, Caradonti M, Varcasia D, Ipohorski G, Votta R, Zylberman M, Romani A, Valdez P, Amalfa F, Lucero C, Fernández Lausi A, Fernández Garces A, Rodríguez C, Chattas A, Farina J, Clara L, and Nuccetelli Y
- Subjects
- Argentina, Female, Humans, Lithotripsy adverse effects, Male, Nephrolithiasis complications, Nephrolithotomy, Percutaneous adverse effects, Prostatitis drug therapy, Prostatitis etiology, Risk Factors, Stents adverse effects, Urinary Catheters adverse effects, Anti-Infective Agents, Urinary therapeutic use, Consensus, Urinary Tract Infections drug therapy, Urinary Tract Infections etiology
- Abstract
The second part of the Inter-Society Argentine Consensus on Urinary Tract Infection (UTI) includes the analysis of special situations. In patients with urinary catheter, urine culture should be requested only in the presence of UTI symptomatology, before instrumentation of the urinary tract, or as a post-transplant control. The antibiotics recommended for empirical treatment in patients without risk factors are third-generation cephalosporins or aminoglycosides. UTIs associated with stones are always considered complicated. In case of obstruction with urosepsis, an emergency drainage should be performed via a percutaneous nefrostomy or ureteral stenting. In patients with stents or ureteral prostheses, such as double J catheters, empirical treatment should be based on epidemiology, prior antibiotics, and clinical status. Before the extracorporeal lithotripsy procedure, bacteriuria should be investigated and antibiotic prophylaxis should be administered in case of positive result, according to the antibiogram. First generation cephalosporins or aminoglycosides are valid alternatives. The use of antibiotic prophylaxis with first-generation cephalosporins or aminoglycosides before percutaneous nephrolithotomy is recommended. Transrectal prostatic biopsy can be associated with infectious complications, such as UTI or acute prostatitis, mainly due to Escherichia coli or other enterobacteria. In patients without risk factors for multiresistant bacteria and negative urine culture, prophylaxis with intravenous amikacin or ceftriaxone is recommended. In patients with positive urine culture, prophylaxis will be performed according to the antibiogram, from 24 hours before to 24 hours post-procedure. For the targeted treatment of post-transrectal biopsy prostatitis, carbapenems for 3-4 weeks are the treatment of choice.
- Published
- 2020
18. [Guidelines for management of community-acquired pneumonia in adults].
- Author
-
Lopardo G, Basombrío A, Clara L, Desse J, De Vedia L, Di Libero E, Gañete M, López Furst MJ, Mykietiuk A, Nemirovsky C, Osuna C, Pensotti C, and Scapellato P
- Subjects
- Adult, Aged, Anti-Bacterial Agents therapeutic use, Community-Acquired Infections diagnosis, Community-Acquired Infections drug therapy, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Humans, Middle Aged, Streptococcus pneumoniae, Pneumonia, Pneumococcal diagnosis, Pneumonia, Pneumococcal drug therapy, Pneumonia, Pneumococcal epidemiology, Pneumonia, Pneumococcal microbiology
- Abstract
Community-acquired pneumonia in adults is a common cause of morbidity and mortality particularly in the elderly and in patients with comorbidities. Most episodes are of bacterial origin, Streptococcus pneumoniae is the most frequently isolated pathogen. Epidemiological surveillance provides information about changes in microorganisms and their susceptibility. In recent years there has been an increase in cases caused by community-acquired meticillin resistant Staphylococcus aureus and Legionella sp. The chest radiograph is essential as a diagnostic tool. CURB-65 score and pulse oximetry allow stratifying patients into those who require outpatient care, general hospital room or admission to intensive care unit. Diagnostic studies and empirical antimicrobial therapy are also based on this stratification. The use of biomarkers such as procalcitonin or C-reactive protein is not part of the initial evaluation because its use has not been shown to modify the initial approach. We recommend treatment with amoxicillin for outpatients under 65 year old and without comorbidities, for patients 65 years or more or with comorbidities amoxicillin-clavulanic/sulbactam, for patients hospitalized in general ward ampicillin-sulbactam with or without the addition of clarithromycin, and for patients admitted to intensive care unit ampicillin-sulbactam plus clarithromycin. Suggested treatment duration is 5 to 7 days for outpatients and 7 to 10 for those who are hospitalized. During the influenza season addition of oseltamivir for hospitalized patients and for those with comorbidities is suggested.
- Published
- 2015
19. [Factors associated to late clinical stage at the initiation of antiretroviral therapy].
- Author
-
Warley E, Fernández Galimberti G, Vieni MI, Tavella S, Salas M, Desse J, D'Agostino G, and Szyld E
- Subjects
- Adolescent, Adult, CD4 Lymphocyte Count, Delayed Diagnosis, Female, HIV Infections diagnosis, Humans, Male, Middle Aged, Odds Ratio, Retrospective Studies, Sex Factors, Socioeconomic Factors, Viral Load, Young Adult, Anti-HIV Agents therapeutic use, Antiretroviral Therapy, Highly Active, HIV immunology, HIV Infections drug therapy
- Abstract
In order to evaluate the frequency of a late clinical stage in HIV infected patients at onset of antiretroviral therapy (LART) and to identify possible associated factors, we performed a retrospective analysis of data reported in two prospective cohorts of HIV infected patients who started antiretroviral therapy for the first time between 2005 and 2009. Medical records of 265 patients -123 women (46.6%) and 141 men, median age 37.7 years old- were analyzed. LART was observed in 132 cases (50%), out of them 102 (77.2%) were associated to late diagnosis of HIV infection and 30 (22.8%) to patients that had not been retained in HIV care. The median of CD4 was 120 cells/ml and that of viral load 58 038 copies/ml. CD4 cells count was below 200 cells/ml in 174 patients (71.3%). There was a higher incidence of LART in men than in women (59.8% and 42.2% respectively). Diagnosis in women took place during pregnancy control in 25:2% of the cases. High alcohol consumption (p 0.006), single hood (p 0.04) and level of education lower than secondary (p 0.008) were associated to LART at bivariate analysis. Male sex (p 0.003) was the only associated factor both in bivariate and multivariate analysis. Our data reinforce the need of expanding HIV testing and should assist programs to define actions promoting early entry in HIV care.
- Published
- 2012
20. [Development of AIDS-related malignancies and infections after starting HAART].
- Author
-
Warley E, Tamayo Antabak N, Desse J, De Luca A, Warley F, Fernández Galimberti G, D'Agostino G, Quintas L, and Szyld E
- Subjects
- AIDS-Related Opportunistic Infections prevention & control, Acquired Immunodeficiency Syndrome complications, Adolescent, Anti-Bacterial Agents therapeutic use, Argentina epidemiology, Azithromycin therapeutic use, CD4 Lymphocyte Count, Female, Humans, Male, Neoplasms etiology, Odds Ratio, Retrospective Studies, Risk Factors, Trimethoprim, Sulfamethoxazole Drug Combination therapeutic use, Viral Load, AIDS-Related Opportunistic Infections epidemiology, Acquired Immunodeficiency Syndrome drug therapy, Antiretroviral Therapy, Highly Active, Neoplasms epidemiology
- Abstract
In order to evaluate the incidence rate and possible risk factors associated with AIDS-related malignancies and infections (ARMI) we performed data analysis of clinical charts of HIV patients in two hospital cohorts, that started high activity antiretroviral therapy (HAART) between July 2003 and October 2007. Trimethoprim-sulfamethoxazole and Azithromycin prophylaxis was provided according to current guidelines. We evaluated development of ARMI six months after-starting HAART and its association with clinical and epidemiological variables. Of 235 patients analyzed -118 women (50.2%) and 117 men (49.8%)- 11 presented ARMI: 3 pulmonary TB and 3 lymph nodes TB cases, 3 cases with meningeal Cryptococcus, one Chagas's disease presenting brain mass and one with non-Hodgkin lymphoma. ARMI incidence: 4.7%. A CD4 cell count < 100/150 was associated with risk of developing ARMI. The mean CD4 cell count was 73 in patients who developed ARMI and 143 in those who did not. No association was found with the other analyzed variables. In the CD4 cell count < 150 group one out of 4 patients with reactive serology presented Chagas's disease causing brain mass; none of the 46 patients with reactive serology presented toxoplasmosis encephalitis. The incidence rate of ARMI was 4.7%. TB in first place and cryptococcosis in second were the AIDS events more frequently observed. A low CD4 cell count was the only observed risk factor statistically associated with development of ARMI. The role of prophylaxis in this population should be re-evaluated.
- Published
- 2010
21. [A study of occupational blood and body fluid exposure among nursing staff at a reference hospital in Buenos Aires, Argentina].
- Author
-
Warley E, Pereyra N, Desse J, Cetani S, de Luca A, Tamayo Antabak N, and Szyld E
- Subjects
- Adult, Argentina, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Nursing Staff, Hospital, Body Fluids, Occupational Exposure statistics & numerical data
- Abstract
Objectives: To determine the frequency of occupational blood and body fluids exposure (OBBFE) among the nursing staff at the Dr. Diego Paroissien Hospital in Buenos Aires, Argentina; analyze the possible risk factors associated; and assess the level of knowledge regarding universal precautions and control procedures following exposure:, Methods: A cross-sectional descriptive study was performed using a voluntary and anonymous survey administered between April and May 2005. In addition to personal and professional data, information was collected on knowledge and practice of universal precautions and procedures, OBBFE experienced, barriers to following the standards, and whether or not the Hepatitis B vaccine had been received. The dependent variable in the analysis was ever having experienced an OBBFE accident:, Results: Of the 186 responses analyzed, 77.7% were female, the mean age was 44.6 +/- 8.9 years, and the institution was 13.3 +/- 6.4 years old. Of those surveyed, 91 (48.9%) indicated that at some time they had an OBBFE, with 33 (17.7%) of these having occurred during the previous year; 73.0% confirmed that the tools necessary for complying with universal precautions were available always or almost always; 76.2% felt they had complete information, although 56.3% said they had not received adequate training; and, 94.1% claimed to have been vaccinated against Hepatitis B. Being overworked (54.5%), insufficient training (21.8%), and a lack of protective tools (18.8%) were the reasons most often identified as impeding compliance with universal precaution guidelines. Not having received training during the preceding year and having recently started work in a clinical or adult intensive-care unit were significantly associated with having experienced an OBBFE:, Conclusions: These results signal a risk alert for OBBFE among health care workers and underscore the need for improving standards and surveillance.
- Published
- 2009
- Full Text
- View/download PDF
22. [Characteristics of HIV infection by sex in a suburban district of Buenos Aires for the periods 1998 to 2002 and 2003 to 2005].
- Author
-
Warley E, Tamayo Antabak N, Desse J, De Luca A, Warley F, Salas M, Vieni I, Szyld E, and Indyk D
- Subjects
- Adult, Anti-HIV Agents therapeutic use, Argentina epidemiology, CD4 Lymphocyte Count, Female, HIV Infections drug therapy, HIV Infections prevention & control, HIV Infections transmission, Humans, Male, Pregnancy, Sex Distribution, Sex Factors, Urban Population, Viral Load, HIV Infections epidemiology
- Abstract
With the aim of evaluating gender differences in one of the poorest districts of Buenos Aires, we reviewed epidemiological and clinical data of newly-diagnosed HIV patients at the Diego Paroissien Hospital between 1998 and 2005.We analyzed 524 clinical charts, 329 (62.8%) of which were from the 1998 to 2002 period and 195 (37.2%) from 2003 to 2005. Women accounted for 241 (46%) of the patients. The dominant mode of transmission was sexual intercourse in women and intravenous drug-use in men. At the time of diagnosis, women were at a significantly lower clinical stage, were younger, and had higher CD4 counts and lower viral loads. No gender differences were found in the rates of continued clinical care or continued antiretroviral therapy at one year follow-up. Comparing the periods 1998 to 2002 and 2003 to 2005, there was a statistically significant increase in diagnoses made during the pregnancy screening in women, in sexual transmission as the primary route of HIV infection, in the frequency of patients (both men and women) who had continued clinical care at one year follow-up, and a decreasing of intravenous drug-use in both sexes.The observed gender differences in the 2003-2005 period persisted even when those women who were diagnosed during their pregnancy screening were excluded from the analysis.
- Published
- 2009
23. [Occupational exposure to hepatitis C virus].
- Author
-
Warley E, Desse J, Szyld E, Silva FN, Cetani S, Pereyra N, De Luca A, and Gurtman A
- Subjects
- Argentina epidemiology, Enzyme-Linked Immunosorbent Assay, Follow-Up Studies, HIV Infections prevention & control, HIV Infections transmission, Hepacivirus isolation & purification, Hepatitis C epidemiology, Humans, Retrospective Studies, Hepatitis C transmission, Infectious Disease Transmission, Patient-to-Professional statistics & numerical data, Occupational Exposure statistics & numerical data
- Abstract
Occupational exposure to Hepatitis C virus is an area of growing concern due to a lack of prophylaxis and limited knowledge regarding prevalence in hospital environment. Between 1999 and 2003, a total of 128 occupational exposures to this virus were registered in Diego Paroissien Hospital, eight of which led to hepatitis (6.3%) and one case to serum conversion (0.8%). Currently there is no preventive therapy and great interest is focused on acute infection therapy the effectiveness of which is still controversial. This study reinforces the fact that adherence to the Universal Precautions is still the most important preventive measure for health care workers, and the most cost beneficial.
- Published
- 2006
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.